Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 12, Décembre 2014
Page(s) 1078 - 1080
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20143012008
Publié en ligne 24 décembre 2014
  1. Lersch C, Schmelz R, Eckel F, et al. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin colorectal canc 2002 ; 2 : 54–58. [CrossRef]
  2. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995 ; 18: 775–794. [CrossRef] [PubMed]
  3. Sies H. Role of reactive oxygen species in biological processes. Klinische Wochenschrift 1991 ; 69 : 965–968. [CrossRef] [PubMed]
  4. Nicco C, Laurent A, Chereau C, et al. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 2005 ; 59 : 169–174. [CrossRef] [PubMed]
  5. Alexandre J, Batteux F, Nicco C, et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006 ; 119 : 41–48. [CrossRef] [PubMed]
  6. Laurent A, Nicco C, Chereau C, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005 ; 65 : 948–956. [PubMed]
  7. Thomas-Schoemann A, Batteux F, Mongaret C, et al. Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer. J Immunol ; 189 : 5171–5177. [CrossRef] [PubMed]
  8. Coriat R, Nicco C, Chereau C, et al. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Mol Cancer Ther ; 11 : 2284–2293. [CrossRef] [PubMed]
  9. Alexandre J, Nicco C, Chereau C, et al. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006 ; 98 : 236–244. [CrossRef] [PubMed]
  10. Gamelin E, Gamelin L, Bossi L, Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Sem Oncol 2002 ; 29 : 21–33. [CrossRef]
  11. Boyette-Davis J, Dougherty PM. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp Neurol 2011 ; 229 : 353–357. [CrossRef] [PubMed]
  12. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995 ; 45: 1848–1855. [CrossRef] [PubMed]
  13. Egashira N, Hirakawa S, Kawashiri T, et al. Mexiletine reverses oxaliplatin-induced neuropathic pain in rats. J Pharmacol Sci 2010 ; 112 : 473–476. [CrossRef] [PubMed]
  14. Sittl R, Carr RW, Fleckenstein J, Grafe P. Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy. Neurotoxicology 2010 ; 31 : 694–700. [CrossRef] [PubMed]
  15. Grolleau F, Gamelin L, Boisdron-Celle M, et al. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001 ; 85 : 2293–2297. [PubMed]
  16. Sytze Van Dam P, Cotter MA, Bravenboer B, Cameron NE. Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. Eur J Pharmacol 2013 ; 719 : 180–186. [CrossRef] [PubMed]
  17. Kirchmair R, Tietz AB, Panagiotou E, et al. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. Mol Ther 2007 ; 15 : 69–75. [CrossRef] [PubMed]
  18. Zochodne DW, Levy D. Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol 2005 ; 51 : 255–267. [PubMed]
  19. Joseph EK, Chen X, Bogen O, Levine JD. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 2008 ; 9 : 463–472. [CrossRef] [PubMed]
  20. Coriat R, Alexandre J, Nicco C, et al. Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir. J Clin Invest 2014 ; 124 : 262–272. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.